Dr Milan Anjanappa, Consultant Clinical Oncologist

Dr Milan Anjanappa

Consultant Clinical Oncologist

Book online
|

Dr Milan Anjanappa MBBS MD FRCR

Consultant Clinical Oncologist

MBBS MD FRCR

Dr Milan Anjanappa

Consultant Clinical Oncologist MBBS MD FRCR

Book online
|
MBBS MD FRCR
HCA-Healthcare-UK

Areas of expertise

  • Prostate cancer
  • Urological cancers
  • Radiotherapy
  • Brachytherapy
  • Systemic cancer treatments
HCA-Healthcare-UK

Address

About Dr Milan Anjanappa

GMC number: 7685535

Year qualified: 2011

Place of primary qualification: Manipal Academy of Higher Education Deemed University - Kasturba Medical College Mangalore

Initial consultation fee: £250

Follow up consultation fee: £175

Dr Milan Anjanappa is a Consultant Clinical Oncologist specialising in the non-surgical treatment of prostate and complex urological cancers. He has held a consultant post at Mount Vernon Cancer Centre in London since 2021 and sees patients privately through HCA Healthcare UK.

He treats prostate cancer at different stages, including newly diagnosed, localised, advanced and recurrent disease. His practice includes the assessment of complex cases and specialist second opinions, including for patients considering alternatives to surgery.

His treatment interests include precision radiotherapy using image-guided, stereotactic and MR-guided techniques, alongside high-dose-rate and low-dose-rate prostate brachytherapy. He also provides hormone therapy, chemotherapy, immunotherapy and targeted cancer treatments.

Dr Anjanappa offers Lu-PSMA radioligand therapy for selected patients with advanced prostate cancer. Treatment may involve a single approach or a combination of therapies, according to the diagnosis, clinical circumstances and the patient's priorities, with attention to quality of life.

Areas of expertise

  • Advanced prostate cancer
  • Brachytherapy
  • Brachytherapy for prostate cancer
  • Cancer care
  • Chemotherapy
  • Clinical trials
  • Hormone therapy
  • Image guided radiotherapy (igrt)
  • Immunotherapy
  • Intensity modulated radiotherapy (imrt)
  • Magnetic resonance linear accelerator (mr linac)
  • Magnetic resonance linear accelerator-guided stereotactic ablative radiotherapy (mrl-sabr)
  • Metastases
  • Oligometastic disease
  • Prostate cancer
  • Radiotherapy
  • Renal (kidney) cancer
  • Stereotactic ablative radiotherapy (sabr)
  • Systemic cancer treatments
  • Targeted therapy
  • Urological (genitourinary) cancers
  • Urological cancers
  • Volume modulated arc therapy (vmat)

Professional memberships

General Medical Council